Using two independent mouse models relying on different pathogenetic mechanisms coupled with functional experiments in tumoroids, we could show that STAT2 promotes CRC and is implicated in the resistance of tumor cells to the anti-cancer agents 5-Fluorouracil and Cisplatin. The gene discussed is STAT2; the disease is cancer.